At Polyplus-transfection®, we are proud to offer our 15 years of experience in the area of bio-molecules delivery to our partners and customers, in the academia, biotech and pharma areas.
We enable scientists to develop breakthrough therapies to improve human health with innovative delivery solutions every step of the way from fundamental research to clinical applications.
We will provide Life Science researchers around the world with gold standard products and services to enable them to stay at the forefront in research, gene therapy and bioproduction.
Polyplus-transfection® SA is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network.
Polyplus-transfection® reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection® holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
Research & Development
Based on its core know-how in the field of nucleic acid delivery, Polyplus-transfection®’s R&D team is focused on the formulation of innovative transfection compounds designed to take advantage of the latest developments in the transfer of bio-molecules. Polyplus-transfection® is a technology leader in chemically mediated transfection, for in vitro as well as for in vivo delivery.